Shilpa Medicare said the US market for Irinotecan HCL is approximately $18 million
from Latest News http://bit.ly/2EYsciU
Tuesday, 1 January 2019
Shilpa Medicare gets USFDA approval for cancer treatment injection
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment